Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Scoop.it!
B Braun has been granted European CE Mark approval for its new Coroflex ISAR stent, for the treatment of stenoses in coronary arteries. 
No comment yet.
Sign up to comment
Scoop.it!
Boston Scientific Corporation (NYSE:BSX) announces U.S. Food and Drug Administration (FDA) approval for the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System, the Company's next-generation drug-eluting stent (DES) technology. The PROMUS Element Stent, designed to provide physicians improved DES performance in treating patients with coronary artery disease, is built on an innovative platinum chromium (PtCr) platform with the market-leading everolimus drug. The Company plans to begin marketing the product in the U.S. immediately.
Scoop.it!
Percutaneous coronary intervention with bare metal stents followed by a course of oral prednisone at immunosuppressive strength produces results comparable to that obtained with drug-eluting stents, an Italian Team has shown.
Scoop.it!
According to the company the trial will examine the “dissolving” heart device compared to Abbott’s drug-eluting stents in patients with coronary artery disease in Japan.
Scoop.it!
Using bare metal stents for many low-risk patients could save more than $200 million annually.
|
Curated by Beeyond
BEEYOND is a consulting company in the field of disruptive innovation, accompanying established companies on out-of-the-core growth strategy, from creation of new concepts to product launch. Reach us at: contact@beeyond.fr.
Other Topics
#dotdot, the community internet
Aidants
Aston-Martin
Augmented & Virtual Reality
Blue Ocean Strategy
Brain Computer Interfaces & connected medical devices
Consumer Digital Health
Covid-19, SARS-Cov-2, vaccines, Remdesivir, Chloroquine...and all that Jazz
Critical Limb-Threatening Ischemia (CLTI)
Daily realities of diabetic patients
Fashion & technology
Healthcare: reloaded...
High level trending in...
In-Vitro Diagnostic
Innovating to what's next...
Instrumental cosmetics
Interventional Cardiology
Intra-Dermal drug delivery: Opportunities and Challenges?
Metabolic Activation Therapy
Multiple sclerosis
Neurovascular Intervention
Nudges
Peritoneal dialysis
Solid tumors: latest on treaments and research pathways
glioblastoma, craniopharyngioma...
SPV
Tailored Expertise Sourcing & Market Intelligence in Global Consulting
The future of e-cigarette
The Revolution Of The Car Industry
Track & Trace
Transcatheter Treatment of Mitral Regurgitation
|
